Nonsugar Sweeteners—Time for Transparency and Caution-Reference-Cited by-同舟云学术

Nonsugar Sweeteners—Time for Transparency and Caution

Published:2024-01-22 Issue: Volume: Page:
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Sylvetsky Allison C.¹,Rebolledo Natalia²,Krieger James W.³⁴

Affiliation:

1. Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, The George Washington University, Washington, DC

2. Center for Research in Food Environments and Prevention of Nutrition-Related Chronic Diseases, Institute of Nutrition and Food Technology, University of Chile, Macul, Chile

3. Healthy Food America, Seattle, Washington

4. Department of Health Systems and Population Health, University of Washington, Seattle, Washington

Abstract

This Viewpoint discusses the growing presence of nonsugar sweeteners (NSSs) in the food supply and mounting concerns about their use, which suggest that disclosure of the amounts of NSS in food and beverages and restrictions on their use in products marketed to children are warranted.

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology and Child Health

Link

https://jamanetwork.com/journals/jamapediatrics/articlepdf/2814105/jamapediatrics_sylvetsky_2024_vp_230045_1704995470.86159.pdf

Reference10 articles.

1. Changes in nonnutritive sweetener intake in a cohort of preschoolers after the implementation of Chile’s Law of Food Labelling and Advertising.;Rebolledo;Pediatr Obes,2022

2. The use of nonnutritive sweeteners in children.;Baker-Smith;Pediatrics,2019

3. Low-calorie sweetened beverages and cardiometabolic health: a science advisory from the American Heart Association.;Johnson;Circulation,2018

4. The effects of low-calorie sweeteners on energy intake and body weight: a systematic review and meta-analyses of sustained intervention studies.;Rogers;Int J Obes (Lond),2021

5. Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies.;Qin;Eur J Epidemiol,2020